Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty

NCT07624526 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT07624526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07624526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
August 31, 2028
Enrollment
75 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis, knee osteoarthritis